arrow_back Back to App

Safe Medicine Act: Boosting US Drug Production and Safety

This bill aims to reduce US reliance on foreign generic drug suppliers, particularly from China. It directs government agencies to develop a strategy to increase domestic production of key medicines and ingredients and requires clear warnings on drugs from countries with manufacturing oversight issues. This is intended to improve the safety and availability of essential medicines for citizens.
Key points
Government must develop a plan to buy more US-made essential medicines and ingredients.
Agencies will work to increase domestic production of critical drugs over the next 5 years.
The FDA can require clear warnings on drug labels if they come from countries with known manufacturing issues.
Limits waivers that could allow buying foreign essential medicines over US-made ones for government use.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5003
Sponsor: Rep. Posey, Bill [R-FL-8]
Process start date: 2021-08-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-04-17
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Safe Medicine Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5003.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-08-10.

What are the main provisions?

Key points include:

  • Government must develop a plan to buy more US-made essential medicines and ingredients.
  • Agencies will work to increase domestic production of critical drugs over the next 5 years.
  • The FDA can require clear warnings on drug labels if they come from countries with known manufacturing issues.
  • Limits waivers that could allow buying foreign essential medicines over US-made ones for government use.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Posey, Bill [R-FL-8].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Oversight and Investigations.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Security